SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000875320-20-000014
Filing Date
2020-04-29
Accepted
2020-04-29 16:14:26
Documents
15
Period of Report
2020-04-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kq12020.htm   iXBRL 8-K 37299
2 EXHIBIT 99.1 ex-991q12020.htm EX-99.1 282599
  Complete submission text file 0000875320-20-000014.txt   485041

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20200429.xsd EX-101.SCH 4516
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20200429_cal.xml EX-101.CAL 693
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20200429_def.xml EX-101.DEF 1543
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20200429_lab.xml EX-101.LAB 26142
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20200429_pre.xml EX-101.PRE 13649
10 EXTRACTED XBRL INSTANCE DOCUMENT a8-kq12020_htm.xml XML 4339
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19319 | Film No.: 20830463
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences